BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 947190)

  • 1. An overview of the analysis and interpretation of bioavailability studies in man.
    Wagner JG
    Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biologic availability and "1st pass" effect of drugs].
    Rietbrock N; Keller F
    Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Absorption and biological availability of drugs].
    Uribe M
    Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics and bioavailability of alizapride (author's transl)].
    Houin G; Bree F; Tillement JP
    Sem Hop; 1982 Feb; 58(6):339-44. PubMed ID: 6280299
    [No Abstract]   [Full Text] [Related]  

  • 5. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
    Cabana BE
    Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological availability].
    Weber E; Gundert-Remy U
    Arzneimittelforschung; 1975 Jul; 25(7a):1158-62. PubMed ID: 1242346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and pharmacokinetic analysis of drug responding systems.
    Smolen VF
    Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
    Lesne M
    J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
    [No Abstract]   [Full Text] [Related]  

  • 9. [Feasibility of the in vitro evaluation of bioavailability. 3: Method of operation of a newly-developed absorption model and results obtained with it].
    Fürst W; Neubert R; Stütz B; Fuchs G; Buchmann E
    Pharmazie; 1982 Aug; 37(8):571-7. PubMed ID: 7146065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bioavailability and its significance in pharmacotherapy].
    Wiela-Hojeńska A; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2003 Jan; 14(79):89-93. PubMed ID: 12712840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical problems in interpreting comparative bioavailability trials.
    Westlake WJ
    Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):342-5. PubMed ID: 1099025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The bioavailability of orally administered drugs with special regard to the liver as a filter for foreign matter].
    Raaflaub J
    Schweiz Med Wochenschr; 1980 Mar; 110(10):354-62. PubMed ID: 7394464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensible prescribing. II--What happens to all the pills they swallow?
    Rawlins MD
    Practitioner; 1975 Feb; 214(1280):274-81. PubMed ID: 1144254
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics and toxicity testing.
    Clark B; Smith DA
    Crit Rev Toxicol; 1984; 12(4):343-85. PubMed ID: 6378530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate: bioavailability and pharmacokinetics.
    Campbell MA; Perrier DG; Dorr RT; Alberts DS; Finley PR
    Cancer Treat Rep; 1985; 69(7-8):833-8. PubMed ID: 3893694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and relative bioavailability of vinylbital in man after oral and rectal administration.
    Breimer DD; de Boer AG
    Arzneimittelforschung; 1976; 26(3):448-54. PubMed ID: 989344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bioavailability and first-pass effects.
    Kwan KC
    Drug Metab Dispos; 1997 Dec; 25(12):1329-36. PubMed ID: 9394021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bioavailability data by practitioners. I: pitfalls in interpreting the data.
    Schumacher GE
    Am J Hosp Pharm; 1975 Aug; 32(8):639-42. PubMed ID: 1146833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioavailability.
    Wagner JG
    Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.